CAESAREA, Israel and EINDHOVEN,
Netherlands, Sept. 20, 2017 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), a smart diabetes solution, and HighTechXL, a
corporate-backed accelerator based in Eindhoven, The Netherlands, announce their strategic
collaboration to bring personalized healthcare management to
diabetes and pre-diabetes patients around the world.
Backed by an alliance of corporations and regional
organizations, including Philips, the HighTechXL Acceleration
program selected DarioHealth because of its strong management team,
innovative business model, and smart solutions for diabetes
management.
DarioHealth develops cloud-based diabetes platforms that include
a native mobile solution helping patients to manage diabetes
related information and a platform that facilitates coaching. The
all-in-one Dario Blood Glucose Monitoring System is capable of
sharing real-time results with healthcare professionals via the
personalized AI-driven application.
Globally, DarioHealth is already cleared by four major
regulatory bodies including Health Canada, CE, TGA, and the U.S.
FDA for both iOS and certain Android devices. The product is
available in the United States,
United Kingdom, Australia, Canada, New
Zealand, The Netherlands,
Israel, and Italy. In addition, DarioHealth has received
reimbursement coverage for plans in the United Kingdom, Australia, Italy, and Canada, and is also covered by 3rd-party
insurance agreements in the United
States.
Guus Frericks, Managing Director
of HighTechXL acknowledges: "We were impressed by DarioHealth's
solution and by the execution capabilities of the company. The
company managed to create and enroll a very user-centric solution
that is truly data-driven and personalized. We believe HighTechXL's
team experience and network can help DarioHealth accelerate its
penetration to market and get its product to millions of patients
over the world."
Erez Raphael, Chairman and CEO of
DarioHealth commented: "We are extremely honored and proud to be
selected by the Philips-backed accelerator. We believe the industry
is transforming from a device-driven industry to a personalized
managed care, data and clinical outcome driven industry. It is
encouraging that Philips' executives share the same vision. We are
looking forward to collaborate with the accelerator team and find
new ways to accelerate our growth."
The HighTechXL Accelerator is a three-month, corporate-backed
program designed to accelerate startups to their next stage of
development, including to help them gain broader customer traction
and secure development partnerships. In addition, the program team
facilitates the possibility for scaling companies to explore
options including starting a pilot project with the corporations
constituting the HighTechXL partner network, or integrating their
product or service into the corporation's existing business
line.
For the selection of its latest batch, the HighTechXL team
invited 75 startups and scale-ups from 23 different countries.
Selected companies were invited to participate in a joint three-day
selection event by HighTechXL and Get in the Ring in collaboration
with ABN AMRO bank, ASML, EY,
NTS-Group, and Philips. 35 of the 75 companies were focused on the
development of healthcare solutions and medical devices.
DarioHealth competed in a medical technology track, during which
companies were given the opportunity to assess the fit of their
business and technology propositions against Philip's current
product lines with executives and innovation managers.
About DarioHealth Corp.
DarioHealth Corp. is a leading
global digital health company serving tens of thousands of users
with dynamic mobile health solutions. We believe people deserve the
best tools to manage their treatment, and harnessing big data, we
have developed a unique way for our users to analyze and
personalize their diabetes management. With our smart diabetes
solution, users have direct access to track and monitor all facets
of diabetes, without having the disease slow them down. The
acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood
glucose meter and native smartphone app gives users an unrivaled
method for self-diabetes management. DarioHealth is headquartered
in Caesarea, Israel with a
regional office in Burlington,
Massachusetts. For more information, visit
http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify
forward-looking statements. For example, when the Company describes
the potential benefits of the collaboration with HighTechXL, and
when the Company describes its beliefs in industry trends, it is
using forward-looking statements. Readers are cautioned that
certain important factors may affect the Company's actual results
and could cause such results to differ materially from any
forward-looking statements that may be made in this news release.
Factors that may affect the Company's results include, but are not
limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product
development, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and
economic risks, and the risks associated with the adequacy of
existing cash resources. Additional factors that could cause or
contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
About HighTechXL
HighTechXL is an innovation hub which
accelerates innovative solutions to market success. We help startup
founders and corporations alike. With a main office at the High
Tech Campus Eindhoven, HighTechXL runs effective acceleration and
launchpad programs which support entrepreneurs and in-corporate
ventures throughout all chapters of their entrepreneurial quest -
from idea to prototype to scale-up. The comprehensive programs are
backed by the leading high-tech, med tech and financial actors in
the region: ABN AMRO, ASML, BOM, EY,
NTS-Group and Philips, forging an open innovation ecosystem where
the strengths of both the startup and corporate worlds complement
each other to create new and sustainable business opportunities.
HighTechXL is headquartered in Eindhoven, the Netherlands with offices in Shanghai, China and Boston, the U.S.
High Tech Campus 1, 5656 AE Eindhoven
http://www.hightechxl.com/
http://www.facebook.com/hightechxl
http://www.twitter.com/Hightechxl
http://www.linkedin.com/company/hightechxl
https://www.f6s.com/hightechxlhardwareaccelerator2016
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
1-914-775-5548
DarioHealth Investor Relations Contact
Hayden IR
Stephen Hart
DRIO@HaydenIR.com
1-917-658-7878
View original content with
multimedia:http://www.prnewswire.com/news-releases/dariohealth-joins-philips-backed-innovation-hub-hightechxl-to-empower-more-diabetes-patients-to-analyze-and-personalize-their-treatment-300522200.html
SOURCE DarioHealth Corp. and HighTechXL